Lycopene
Also called: tomato lycopene
Lycopene is a carotenoid pigment made by plants and microorganisms, found in tomatoes, tomato products, watermelon, guava, rose hips and pink grapefruit. The body does not convert it into vitamin A. Supplement studies have used tomato-based and synthetic lycopene.
- Category
- Other
- Forms
- Lycopene from tomato extracts or synthetic lycopene (both studied in supplements)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-30
Class 2 Moderately studied in people. A 2011 Cochrane review included three RCTs (154 men) randomizing men to lycopene or a comparison group. A 2021 meta-analysis pooled six RCTs, but its abstract does not show that each tested lycopene alone, so it was not counted. [4]
Fact-checked 2026-10-30 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CBrain, mood and sleep1 topic
CLungs and airways1 topic
CHeart and blood vessels1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| PSA levels in men with non-metastatic prostate cancer | C | A 2021 meta-analysis of six RCTs found no significant overall effect of lycopene supplementation on PSA (WMD −0.60 µg/L); a reduction appeared only in studies of men with baseline PSA of 6.5 µg/L or higher. [3] |
| Prostate cancer incidence | C | A Cochrane review found three RCTs (154 participants), two at high risk of bias, and concluded the evidence was insufficient to support or refute lycopene; only one trial reported prostate cancer incidence. [4] |
| Cardiovascular risk factors (tomato products and lycopene supplements) | C | A 2017 meta-analysis of 21 intervention trials found lycopene supplementation reduced systolic blood pressure by 5.66 mmHg; tomato interventions reduced LDL cholesterol and IL-6 and improved flow-mediated dilation. [5] |
| Blood pressure and blood lipids (dietary or supplemental lycopene) | C | A 2020 review of 43 studies (1.44 to 75 mg/day, food or supplement) found no significant differences between lycopene and control groups for blood pressure or lipids; findings across studies conflicted. [6] |
| Exercise-induced asthma | C | MSK: one clinical trial reported that daily lycopene supplementation protected against exercise-induced asthma; no additional studies have been performed to confirm this. [1] |
Main constituents: Lycopene, a carotenoid pigment [1]; Lycopene is a non-provitamin A carotenoid (not converted into vitamin A) [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Cardiovascular studies used 1.44 to 75 mg lycopene/day; the dose was not reported in 11 of 43 studies. [6]
- A 28-day bioavailability trial gave 15 mg/day total lycopene with the main meal. [7]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
Interactions
| With | What happens |
|---|---|
| Alcohol | MSK: a possible interaction between lycopene and alcohol consumption was demonstrated in an animal model; clinical relevance is not known. [1] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- MSK reports that lycopene content in six commercial brands varied from the labeled dosage by as much as 43%. [1]
Regulatory status
- US: No NDI notification naming lycopene was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [8]
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; a firm is responsible for ensuring its products are not adulterated. [9]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Lycopene, a carotenoid pigment synthesized by plants and microorganisms Carotenoids [P1]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming lycopene was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of lycopene was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- MSK: a possible interaction between lycopene and alcohol consumption was demonstrated in an animal model; clinical relevance is not known. [P1]
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]
- Lycopene content assay against label claim — Lycopene content in six commercial brands varied from the labeled dosage by as much as 43% (MSK). [P1]
Supply and conservation
Absorption in people
- In two men given 10 mg synthetic lycopene with a 14C-lycopene tracer, plasma tmax of total 14C-lycopene was 6 h and elimination half-life 5 days; lycopene was extensively isomerized (92% all-trans at dosing, 50% trans after 24 h). [P6]
- Lycopene or its metabolites were detected in skin for up to 42 days after a single dose. [P6]
- Over 28 days at 15 mg/day, synthetic and tomato-based lycopene raised serum total lycopene by 0.58 and 0.57 µmol/L (12 people per group); the responses did not differ significantly. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Memorial Sloan Kettering Cancer Center. About Herbs: Lycopene (Last Updated May 6, 2022), 2022-05-06. mskcc.org
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- Hoppe PP, et al. Synthetic and tomato-based lycopene have identical bioavailability in humans. Eur J Nutr 2003;42(5):272-8 (PMID 14564460), 2003-10. pubmed.ncbi.nlm.nih.gov
- Ross AB, et al. Lycopene bioavailability and metabolism in humans: an accelerator mass spectrometry study. Am J Clin Nutr 2011;93(6):1263-73 (PMID 21543537), 2011-06. pubmed.ncbi.nlm.nih.gov
Sources
- Memorial Sloan Kettering Cancer Center. About Herbs: Lycopene (Last Updated May 6, 2022), 2022-05-06. mskcc.org
- NIH Office of Dietary Supplements. Vitamin A and Carotenoids: Fact Sheet for Health Professionals (Updated March 10, 2025), 2025-03-10. ods.od.nih.gov
- Sadeghian M, et al. Lycopene does not affect prostate-specific antigen in men with non-metastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials. Nutr Cancer 2021;73(11-12):2796-2807 (PMID 33355018), 2021. pubmed.ncbi.nlm.nih.gov
- Ilic D, et al. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev 2011;(11):CD008007 (PMID 22071840), 2011-11-09. pubmed.ncbi.nlm.nih.gov
- Cheng HM, et al. Tomato and lycopene supplementation and cardiovascular risk factors: a systematic review and meta-analysis. Atherosclerosis 2017;257:100-108 (PMID 28129549), 2017-02. pubmed.ncbi.nlm.nih.gov
- Tierney AC, et al. Effect of dietary and supplemental lycopene on cardiovascular risk factors: a systematic review and meta-analysis. Adv Nutr 2020;11(6):1453-1488 (PMID 32652029), 2020-11-16. pubmed.ncbi.nlm.nih.gov
- Hoppe PP, et al. Synthetic and tomato-based lycopene have identical bioavailability in humans. Eur J Nutr 2003;42(5):272-8 (PMID 14564460), 2003-10. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.